Characterization of bacterial isolates cultured from the nasopharynx of children with sickle cell disease (SCD)
Background: We characterized bacterial isolates from the nasopharynx of 84 Sickle cell disease patients 78 of whom were HbSS and 6 HbSC aged 4 four months to 15 years at Wesley Guild Hospital, Ilesa, southwestern Nigeria between February – September, 2014.
Method: Sterile cotton-tipped initially dipped into sterile saline thereafter was introduced into nasopharynx of each patient and thereafter applied onto sterile thioglycolate medium and incubated at 370 C for 24 hr, When growth was noticed, samples were inoculated onto enriched, selective and differential bacteriologic media. Bacterial colonies that grew on such media were picked and characterized by gram reaction, cultural, morphologic and biochemical methods. Antibiotic sensitivity tests were determined by the disc diffusion method. Demographic data relating to severity of SCD were provided.
Results: Altogether, 119 isolates were cultured from the nasopharynx. Gram positive bacteria predominated (65.54%) and Corynebacterium spp (44.53%) dominated comprising of 19 (35.84%) Corynebacterium xerosis 11 (20.75%) Corynebacterium diphtheriae, 10(18.86) Corynebacterium pseudodiphtheriticum, 8(15.09%) Corynebacterium ulcerans, 3(6.66%) Corynebacterium spp and 2(3.77%) Corynebacterium jeikeium. Other Gram positive rods cultured were Arcanobacterium haemolyticum 6(5%). Bacillus subtilis was 3 (2.5%), Actinomyces isrealli 3 (2.5%) and Norcadia asteroids 1 (0.84%). Low frequency of nasopharyngeal colonization recorded for Haemophilus influenzae 4.2%, and S. pneumoniae 2.5% and S. aureus 4(3.36%) and multiresistance was widespread for most isolates.
Conclusion: Indigenous microflora Corynebacterium spp predominated and low rate of nasopharyngeal colonization with H. influenzae, and S. pneumoniae recorded attributable to prophylactic use of penicillin and vaccines administration probably suppressed growth of organisms and inevitably increased resistance to many antibiotics.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).